Guido Oelkers

Germanybusiness executiveMale5.0Global Dominance: 0.00%

Guido Oelkers has been named the successor to Uğur Şahin as the CEO of BioNTech, effective no later than February 1, 2027. He has an extensive background in the biopharma sector, having previously led Swedish Orphan Biovitrum (Sobi) and worked for Hoechst AG in the 1990s.